Whey Protein Hydrolysate 7051
Whey Protein Hydrolysate 7051 is a high quality, partially hydrolysed (12%) specialty protein designed specifically for infant formula and medical nutrition. It is produced by controlled enzyme treatment of whey protein to deliver readily available and easily absorbed amino acids, peptides and polypeptides. A suitable protein replacement for non-breastfed infants and may help reduce the risk of developing cow's milk protein allergy in infants.
Features:
- Degree of hydrolysis 12%
- Reduced allergenicity determined by ELISA assay for beta-lactoglobulin
- Excellent solubility
- Good tasting hydrolysate with lower bitterness relative to typical hydrolysates
- Good dispersibility
- Origin: USA
Disclaimer: While we try to represent product images accurately, the representation on your screen may be different to the actual product for various reasons.
Disclaimer: While we try to represent product images accurately, the representation on your screen may be different to the actual product for various reasons.
Explore applications
Key benefits
Title
Please add a copy here.
References
- [1] *WPH 7051 has been assessed by EFSA as a nutritionally safe and suitable protein source for use in infant and follow‐on formula, when used at a minimum of 2.0 g/100 kcal protein and complies with the compositional criteria of Regulation (EU) 2016/127 and the amino acid pattern in its Annex IIIA
- [2] Koopman et al. (2009)
- [3] Dallas et al. (2012)